FDA Approved: GLATOPA — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for GLATOPA (glatiramer acetate) submitted by Sandoz Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• GLATOPA (GLATIRAMER ACETATE)

Snippet

SUPPL AP for GLATOPA (GLATIRAMER ACETATE)